Attralus, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.attralus.com
Attralus Enrolls First Subject in Phase 1 Clinical Trial for AT-02, a Pan-Amyloid Removal Therapeutic
Attralus, Inc. has announced the enrollment of the first subject in its Phase 1 clinical trial for AT-02, a novel therapeutic aimed at treating systemic amyloidosis by removing toxic amyloid fibrils. The trial will assess the safety, tolerability, and pharmacokinetics of AT-02 in both healthy volunteers and patients with systemic amyloidosis.
© Copyright 2025. All Rights Reserved by MedPath